PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Stroke10.5853/jos.2022.021452023251169-172Association of Substantia Nigra Degeneration with Poor Neurological Recovery in Basal Ganglia InfarctionsKijeong Lee, HyungWoo Lee, Young Dae Kim, Hyo Suk Nam, Hye Sun Lee, Joonsang Yoo, Sunghee Cho, Ji Hoe Heohttp://j-stroke.org/upload/pdf/jos-2022-02145.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2022.02145, http://j-stroke.org/upload/pdf/jos-2022-02145.pdf
Basal Ganglia10.1016/j.baga.2015.02.263201551XXII-XXIIIDegeneration des nigrostriatalen Systems durch AAV1/2 vermittelte Überexpression von mutiertem A53T alpha-Synuclein in der Substantia nigra: ein neues Mausmodell des M. ParkinsonChi Wang Iphttps://api.elsevier.com/content/article/PII:S221053361500266X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S221053361500266X?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2011.01.06820111135P148 No correlation between substantia nigra (SN) hyperechogenicity and dopaminergic degeneration measured by FP-CIT-SPECT in idiopathic parkinson’s disease (IPS)E. Lobsien, S. Schreiner, A. Kupsch, M. Plotkin, S.J. Schreiber, F. Doepphttps://api.elsevier.com/content/article/PII:S2210533611000694?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210533611000694?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2015.02.243201551XVDifferentielle morphologische und funktionelle Darstellung der Substantia nigra bei Patienten mit M. ParkinsonDavid Weisehttps://api.elsevier.com/content/article/PII:S2210533615002464?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210533615002464?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2015.02.262201551XXIIAnalyse humaner Neuromelanin Granula aus post mortem Substantia nigra Gewebe im Kontext der ParkinsonerkrankungSarah Plumhttps://api.elsevier.com/content/article/PII:S2210533615002658?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210533615002658?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2017.02.020201787Volumetry of substantia nigra hyperechogenity in Parkinson's diseaseNorbert Brüggemann, Julia Graf, Marco Maaß, Achim Schweikard, Philipp Jauer, Sophia Lammershttps://api.elsevier.com/content/article/PII:S221053361730028X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S221053361730028X?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2015.02.272201551XXVITherapeutische Effekte gezielter Tiefer Hirnstimulation in der Substantia nigra auf axiale Symptome des Morbus Parkinson: ein FallberichtPeter Ludewighttps://api.elsevier.com/content/article/PII:S2210533615002750?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210533615002750?httpAccept=text/plain
Gaba and the Basal Ganglia - From Molecules to Systems10.1016/s0079-6123(06)60009-52007151-172The pars reticulata of the substantia nigra: a window to basal ganglia outputJ.M. Deniau, P. Mailly, N. Maurice, S. Charpierhttps://api.elsevier.com/content/article/PII:S0079612306600095?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0079612306600095?httpAccept=text/plain
Handbook of Basal Ganglia Structure and Function, Second Edition10.1016/b978-0-12-802206-1.00015-52016293-316The Substantia Nigra Pars ReticulataF.M. Zhouhttps://api.elsevier.com/content/article/PII:B9780128022061000155?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128022061000155?httpAccept=text/plain
Basal Ganglia10.1016/j.baga.2011.01.06420111133-34P144 Substantia nigra hyperechogenicity and MIBG scintigraphy findings are of different value in the diagnostic of Parkinson’s diseaseS. Behnke, J. Bürmann, C. Holzhoffer, K. Faßbender, U. Dillmann, J. Spiegelhttps://api.elsevier.com/content/article/PII:S2210533611000657?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210533611000657?httpAccept=text/plain